Evidence map›Paper›PMID 40527120›Full record

ArticleClinical nutrition (Edinburgh, Scotland)2025

Activating nuclear receptor subfamily 2 group F member 2 in adipocyte stem cells rescues beige adipocyte metabolism impaired by excess early-life omega-6 fatty acids.

Snehasis Das, Rohan R Varshney, Jacob W Farriester, Gertrude Kyere-Davies, Alexandrea E Martinez, Kaitlyn B Hill, Michael Kinter, Gregory P Mullen, Prabhakara R Nagareddy, Michael C Rudolph

Abstract read
In one paragraph

Article in Clinical nutrition (Edinburgh, Scotland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Snehasis DasDepartment of Biochemistry and Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
Rohan R VarshneyDepartment of Biochemistry and Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
Jacob W FarriesterDepartment of Biochemistry and Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
Gertrude Kyere-DaviesDepartment of Biochemistry and Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
Alexandrea E MartinezDepartment of Biochemistry and Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
Kaitlyn B HillDepartment of Biochemistry and Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
Michael KinterAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Gregory P MullenDepartment of Biochemistry and Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
Prabhakara R NagareddyDeptartment of Internal Medicine, Cardiovascular Section, The University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
Michael C RudolphDepartment of Biochemistry and Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA. Electronic address: michael-rudolph@ouhsc.edu.

Funding

Proteomics CoreP20GM103447 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI David W Dyer · 2012 to 2026
$60.2M
Supplement for Google cloud build-outR24GM137786 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Alan Tackett · 2020 to 2026
$15.4M
5-Laser Cytek Aurora Spectral Flow CytometerS10OD028479 · OD · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 2020 to 2020
$317k
Early Life n-3 Fatty Acids Increase Novel Adipogenesis-Regulatory Cells to Condition Adipogenesis in a NR2F2 Dependent MannerR03DK122189 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI RUDOLPH, MICHAEL C. · 2019 to 2020
$225k
NR2F2 Pioneers Neonatal Beige Adipogenesis to Protect Against Later-life ObesityR56DK139005 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI RUDOLPH, MICHAEL C. · 2025 to 2025
$107k
NIDDK NIH HHS R03 DK122189NIDDK NIH HHS R56 DK139005NIGMS NIH HHS P20 GM103447NIGMS NIH HHS R24 GM137786NIH HHS S10 OD028479
6 · The paper itself

Abstract

BACKGROUND AND

aimsDevelopmental exposure to an elevated ratio of omega-6 (n6) to omega-3 (n3) fatty acids (FA) is linked to increased infant body fat and risk of future childhood obesity. We demonstrated in mice that the high n6/n3 developmental exposure reduced nuclear receptor subfamily 2 group F member 2 (NR2F2) in Adipocyte Stem Cells (ASCs), coincident with an altered ASC mitochondrial expression profile and increased white adipose accumulation in pups. This suggested that NR2F2-low ASCs might adopt a nutrient-storage phenotype. Here, we tested the hypothesis that NR2F2 is required in ASCs to undergo beige adipogenesis and metabolism needed during postnatal life for energy and thermogenesis.

methodsC57BL/6J dams were randomized to either n6-rich or balanced n6/n3 control diets at the time of mating and underwent normal gestation and parturition. On postnatal day 12 (PND12), whole-body offspring metabolism was quantified by indirect calorimetry in conjunction with

resultsExcess developmental n6-FA exposure reduced whole-body

conclusionsThese findings demonstrate that excess n6-FA developmental exposure disrupts NR2F2-mediated ASC fate determination, leading to formation of nutrient-storing, lipogenic adipocytes. This work highlights NR2F2 as an important upstream or parallel regulator necessary for beige adipogenesis and underscores its activation as a potential therapeutic approach to mitigate early-life obesity risk. GEO RECORD: GSE284936; Token = orkvgqayblshjsds.

Indexed as

Adipocytes, BeigeCOUP Transcription Factor IIFatty Acids, Omega-6Stem CellsAdipogenesisAnimalsEnergy MetabolismFemaleMaleMiceMice, Inbred C57BLThermogenesisCOUP Transcription Factor IIFatty Acids, Omega-6Adipocyte stem-like cellsEarly-life adipocyte developmentMetabolic programmingNuclear receptor subfamily 2 group F member 2Omega-6 fatty acids

Identifiers

PMID40527120
PMCPMC12257918

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.